Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zoetis

161.30
-1.8700-1.15%
Post-market: 161.300.00000.00%18:29 EDT
Volume:1.58M
Turnover:256.46M
Market Cap:72.23B
PE:29.49
High:164.35
Open:163.31
Low:160.25
Close:163.17
Loading ...

Company Profile

Company Name:
Zoetis
Exchange:
NYSE
Establishment Date:
1950
Employees:
13800
Office Location:
10 Sylvan Way,Parsippany,New Jersey,United States
Zip Code:
07054
Fax:
- -
Introduction:
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Directors

Name
Position
Kristin C. Peck
Chief Executive Officer and Director
Michael B. McCallister
Chairman and Director
Antoinette R. Leatherberry
Director
Frank A. D'Amelio
Director
Gavin D.K. Hattersley
Director
Gregory Norden
Director
Louise M. Parent
Director
Paul M. Bisaro
Director
Robert W. Scully
Director
Sanjay Khosla
Director
Vanessa Broadhurst
Director
Willie M. Reed
Director

Shareholders

Name
Position
Kristin C. Peck
Chief Executive Officer and Director
Wetteny Joseph
Executive Vice President and Chief Financial Officer
Jamie Brannan
Executive Vice President and Chief Commercial Officer
Jeannette Ferran Astorga
Executive Vice President, Corporate Affairs, Communications and Chief Sustainability Officer
Julie Fuller
Executive Vice President, Chief Human Resources Officer and Global Operations
Keith Sarbaugh
Executive Vice President and Chief Digital and Technology Officer
Nick Ashton
Executive Vice President and President, Global Manufacturing and Supply
Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development and Global BioDevices
Robert J. Polzer
Executive Vice President and President, Research and Development
Roxanne Lagano
Executive Vice President, General Counsel and Corporate Secretary